FDAnews
www.fdanews.com/articles/138102-sagent-pharmaceuticals-announces-fda-approval-of-polymyxin-b-for-injection-usp

Sagent Pharmaceuticals Announces FDA Approval of Polymyxin B for Injection, USP

July 5, 2011
Sagent Pharmaceuticals announced FDA approval of polymyxin B for injection, USP, an antibacterial drug, in 500,000 units per vial, latex-free glass vials.
IEWY News